All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

259

Reset

259 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • efocipegtrutideHM15211Phase 21 trial

    Hanmi Pharmaceutical Company Limited · NASH - Nonalcoholic Steatohepatitis

  • EL219Phase 21 trial

    Elion Therapeutics, Inc. · Invasive Mould Infection

  • GBS-06Phase 21 trial

    Inventprise Inc. · Group B Streptococcal Infections

  • GC4006APhase 21 trial

    GC Biopharma Corp · Covid-19 Prevention

  • GS-1179Phase 21 trial

    Gilead Sciences · HSV-2 Infection

  • GS-4321Phase 21 trial

    Gilead Sciences · Chronic Hepatitis Delta

  • GSK3036656Phase 21 trial

    GSK · Tuberculosis

  • GSK3528869APhase 21 trial

    GSK · Hepatitis B, Chronic

  • GSK3772701Phase 21 trial

    GSK · Malaria, Falciparum

  • GSK5800544APhase 21 trial

    GSK · Influenza, Human

  • HH-006Phase 21 trial

    Huahui Health · Chronic Hepatitis B Virus Infection

  • HR19042Phase 21 trial

    Jiangsu HengRui Medicine Co., Ltd. · Autoimmune Hepatitis

  • HRS9950Phase 21 trial

    Chengdu Suncadia Medicine Co., Ltd. · Chronic Hepatitis B

  • IbezapolstatACX-362EPhase 21 trial

    Acurx Pharmaceuticals Inc. · Clostridium Difficile Infection Recurrence

  • IMNN-101Phase 21 trial

    Imunon · SARS CoV 2 Infection

  • INNA-051Phase 21 trial

    ENA Respiratory Pty Ltd · Viral Respiratory Infection, Viral Respiratory Illnesses

  • JCXH-105Phase 21 trial

    Immorna Biotherapeutics, Inc. · Herpes Zoster (HZ), Infectious Diseases, Shingles

  • JDB0131Phase 21 trial

    WestVac Biopharma Co., Ltd. · Tuberculosis, Multidrug Resistant Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis

  • JL18008Phase 21 trial

    Jecho Biopharmaceuticals Co., Ltd. · HIV Infections

  • LipovirtidePhase 21 trial

    Shanxi Kangbao Biological Product Co., Ltd. · HIV

  • LP-98Phase 21 trial

    Shanxi Kangbao Biological Product Co., Ltd. · HIV

  • LW231Phase 21 trial

    Shanghai Longwood Biopharmaceuticals Co., Ltd. · Chronic HBV Infection

  • M5717Phase 21 trial

    Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany · Malaria Infection

  • MK-1439APhase 21 trial

    Merck & Co. · Human Immunodeficiency Virus (HIV) Infection

  • MRG-001Phase 21 trial

    MedRegen LLC · Alcoholic Hepatitis, Acute Alcoholic Hepatitis

  • OVX836Phase 21 trial

    Osivax · Influenza

  • PirmitegravirPhase 21 trial

    ST Pharm Co., Ltd. · HIV-1-infection

  • PRGN-2012Phase 21 trial

    Precigen, Inc · Recurrent Respiratory Papillomatosis, Papillomavirus Infections, Papillomaviridae

  • QL2401Phase 21 trial

    Qilu Pharmaceutical Co., Ltd. · Metabolic Dysfunction-associated Steatohepatitis (MASH)

  • RatutrelvirPhase 21 trial

    Traws Pharma, Inc. · COVID - 19

  • RG002Phase 21 trial

    RinuaGene Biotechnology Co., Ltd. · Human Papillomavirus Associated Intraepithelial Neoplasia, Cervical Intraepithelial Neoplasia Grade 2/3, Human Papillomavirus Type 16 Infection

  • RibaxamasePhase 21 trial

    Theriva Biologics, Inc. · Acute Graft-Versus-Host Reaction Following Bone Marrow Transplant, Prevention of CDI in Adult Patients Being Treated With IV Beta-lactam Antibiotics

  • RSP-1502Phase 21 trial

    Respirion Pharmaceuticals Pty Ltd · Cystic Fibrosis Lung, Respiratory Infections, Recurrent, Chronic, Pseudomonas Aeruginosa

  • RuzasvirAT-038Phase 21 trial

    Atea Pharmaceuticals, Inc. · Chronic Hepatitis C Virus, Hepatitis C, Chronic, Hepatitis C

  • SCB-1019TPhase 21 trial

    Clover Biopharmaceuticals AUS Pty · RSV Infection, Human Metapneumovirus Infection, Parainfluenza Infection

  • SCB-1022Phase 21 trial

    Clover Biopharmaceuticals AUS Pty · RSV Infection, Human Metapneumovirus Infection, Parainfluenza Infection

  • SCB-1033Phase 21 trial

    Clover Biopharmaceuticals AUS Pty · RSV Infection, Human Metapneumovirus Infection, Parainfluenza Infection

  • SCG101Phase 21 trial

    SCG Cell Therapy Pte. Ltd. · Hepatitis B Virus Related Hepatocellular Carcinoma, Hepatocellular Carcinoma Recurrent

  • SCTV02Phase 21 trial

    Sinocelltech Ltd. · Respiratory Syncytial Virus

  • SCTV04CRecombinant Herpes Zoster Vaccine -DosePhase 21 trial

    Sinocelltech Ltd. · Herpes Zoster

  • SNP-610Phase 21 trial

    Sinew Pharma Inc. · NASH - Nonalcoholic Steatohepatitis

  • SUM-191Phase 21 trial

    Senju USA, Inc. · Bacterial Conjunctivitis

  • SYH2066Phase 21 trial

    CSPC Ouyi Pharmaceutical Co., Ltd. · Respiratory Syncytial Virus Infections

  • SYH2085Phase 21 trial

    CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Influenza

  • SYN-004Phase 21 trial

    Theriva Biologics, Inc. · Acute Graft-Versus-Host Reaction Following Bone Marrow Transplant, Prevention of CDI in Adult Patients Being Treated With IV Beta-lactam Antibiotics

  • TAK-242Phase 21 trial

    Yaqrit Ltd · Acute-On-Chronic Liver Failure, Alcoholic Hepatitis, Liver Cirrhosis, Alcoholic

  • TGM-312-SC01Phase 21 trial

    Tangram Therapeutics Plc · Healthy Participants, MASH - Metabolic Dysfunction-Associated Steatohepatitis

  • TQA2225AP025Phase 21 trial

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. · Non-alcoholic Steatohepatitis

  • TQA3334Phase 21 trial

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chronic Hepatitis B

  • TQD3524Phase 21 trial

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia

NewerPage 5 of 6Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.